BRAF and melanoma: Resistance to MEK inhibitors in melanoma cells harboring B-Raf or N-Ras mutations leads to increased expression of transcription factor microphthalmia-associated transcription factor (MITF), which subsequently elevated levels of PGC-1α [73].